InsiderClue
Insiders · Profile

Parschauer Karah Herdman

EVP and Chief Legal Officer at Ultragenyx Pharmaceutical · Director at Evolus. Filing since 10 May 2018. CIK 0001677455

RARE Ultragenyx Pharmaceutical Inc. EVP and Chief Legal Officer · 33 trades EOLS Evolus, Inc. Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
RARE Ultragenyx Pharmaceutical Inc.
3 Aug 2026
EVP and Chief Legal Officer
Sold on a plan
1,900
$47.35K
2.0%
RARE Ultragenyx Pharmaceutical Inc.
15 Jun 2026
EVP and Chief Legal Officer
Sold on a plan
1,899
$46.75K
2.0%
RARE Ultragenyx Pharmaceutical Inc.
10 Mar 2026
EVP and Chief Legal Officer
Sold at will
3,508
$79.53K
5.0%
RARE Ultragenyx Pharmaceutical Inc.
6 Mar 2026
EVP and Chief Legal Officer
Sold at will
6,018
$128.79K
7.9%
RARE Ultragenyx Pharmaceutical Inc.
2 Mar 2026
EVP and Chief Legal Officer
Sold at will
8,135
$185.48K
9.6%
RARE Ultragenyx Pharmaceutical Inc.
12 Sep 2025
EVP and Chief Legal Officer
Sold at will
2,450
$76.37K
3.2%
EOLS Evolus, Inc.
12 Mar 2025
Director
Sold at will
12,888
$167.47K
28.6%
RARE Ultragenyx Pharmaceutical Inc.
3 Mar 2025
EVP and Chief Legal Officer
Sold at will
12,846
$540.82K
14.6%
RARE Ultragenyx Pharmaceutical Inc.
27 Feb 2025
EVP and Chief Legal Officer
Sold at will
2,990
$128.22K
5.2%
RARE Ultragenyx Pharmaceutical Inc.
12 Jun 2024
EVP and Chief Legal Officer
Sold on a plan
9,806
$441.27K
14.5%
RARE Ultragenyx Pharmaceutical Inc.
1 Mar 2024
EVP and Chief Legal Officer
Sold at will
3,756
$201.92K
5.3%
EOLS Evolus, Inc.
30 Jan 2024
Director
Sold on a plan
11,931
$156.73K
27.6%
RARE Ultragenyx Pharmaceutical Inc.
4 May 2023
EVP and Chief Legal Officer
Sold at will
4,378
$197.01K
7.8%
RARE Ultragenyx Pharmaceutical Inc.
1 Mar 2023
EVP and Chief Legal Officer
Sold, plan not stated
3,161
$143.04K
5.3%
RARE Ultragenyx Pharmaceutical Inc.
7 Mar 2022
EVP and Chief Legal Officer
Sold, plan not stated
5,140
$323.56K
13.0%
RARE Ultragenyx Pharmaceutical Inc.
1 Mar 2022
EVP and Chief Legal Officer
Sold, plan not stated
2,886
$192.27K
10.2%
RARE Ultragenyx Pharmaceutical Inc.
14 Oct 2021
EVP and General Counsel
Sold, plan not stated
310
$25.15K
1.1%
RARE Ultragenyx Pharmaceutical Inc.
8 Sep 2021
EVP and General Counsel
Sold, plan not stated
7,336
$738.37K
20.4%
RARE Ultragenyx Pharmaceutical Inc.
10 Jun 2021
EVP and General Counsel
Sold, plan not stated
1,329
$132.90K
4.4%
RARE Ultragenyx Pharmaceutical Inc.
6 May 2021
EVP and General Counsel
Sold, plan not stated
313
$35.58K
1.0%
RARE Ultragenyx Pharmaceutical Inc.
1 Mar 2021
EVP and General Counsel
Sold, plan not stated
3,970
$548.53K
11.6%
RARE Ultragenyx Pharmaceutical Inc.
30 Oct 2020
EVP and General Counsel
Sold, plan not stated
9,903
$991.49K
29.2%
RARE Ultragenyx Pharmaceutical Inc.
28 Oct 2020
EVP and General Counsel
Sold, plan not stated
97
$9.70K
0.4%
RARE Ultragenyx Pharmaceutical Inc.
14 Oct 2020
EVP and General Counsel
Sold, plan not stated
325
$28.60K
1.3%
RARE Ultragenyx Pharmaceutical Inc.
8 Oct 2020
EVP and General Counsel
Sold, plan not stated
10,000
$950.00K
29.2%
RARE Ultragenyx Pharmaceutical Inc.
6 Oct 2020
EVP and General Counsel
Sold, plan not stated
10,000
$900.00K
29.2%
RARE Ultragenyx Pharmaceutical Inc.
23 Sep 2020
EVP and General Counsel
Sold, plan not stated
10,000
$850.00K
29.2%
RARE Ultragenyx Pharmaceutical Inc.
17 Aug 2020
EVP and General Counsel
Sold, plan not stated
12,370
$1.09M
33.7%
RARE Ultragenyx Pharmaceutical Inc.
18 May 2020
EVP and General Counsel
Sold, plan not stated
2,722
$203.37K
9.1%
RARE Ultragenyx Pharmaceutical Inc.
24 Jun 2019
EVP and General Counsel
Sold, plan not stated
1,226
$75.40K
6.5%
RARE Ultragenyx Pharmaceutical Inc.
21 Jun 2019
EVP and General Counsel
Sold, plan not stated
1,489
$93.82K
7.3%
RARE Ultragenyx Pharmaceutical Inc.
29 Apr 2019
EVP and General Counsel
Sold, plan not stated
468
$31.96K
2.3%
RARE Ultragenyx Pharmaceutical Inc.
21 Aug 2018
EVP and General Counsel
Sold, plan not stated
5,000
$392.65K
35.3%
RARE Ultragenyx Pharmaceutical Inc.
21 Jun 2018
EVP and General Counsel
Sold, plan not stated
1,226
$101.48K
8.0%
RARE Ultragenyx Pharmaceutical Inc.
10 May 2018
EVP and General Counsel
Sold, plan not stated
1,465
$87.90K
8.4%
35 decisions on file.